Identification of sibling species of the bryozoan Bugula neritina that produce different anticancer bryostatins and harbor distinct strains of the bacterial symbiont "Candidatus endobugula sertula"
Sk. Davidson et Mg. Haygood, Identification of sibling species of the bryozoan Bugula neritina that produce different anticancer bryostatins and harbor distinct strains of the bacterial symbiont "Candidatus endobugula sertula", BIOL B, 196(3), 1999, pp. 273-280
Although the cosmopolitan marine bryozoan Bugula neritina is recognized as
a single species, natural products from this bryozoan vary among population
s. B. neritina is the source of the anticancer drug candidate bryostatin i,
but it also produces other bryostatins, and different populations contain
different bryostatins. We defined two chemotypes on the basis of previous s
tudies: chemotype: O contains bryostatins with an octa-2,4-dienoate substit
uent (including bryostatin i), as well as other bryostatins; chemotype M la
cks bryostatins with the octa-2,4-dienoate substituent. B. neritina contain
s a symbiotic gamma-proteobacterium "Candidatus Endobugula sertula,'' and i
t has been proposed that bryostatins may be synthesized by bacterial symbio
nts. In this study, B. neritina populations along the California coast were
sampled for genetic variation and bryostatin content. Colonies that differ
in chemotype also differ genetically by 8% in the mitochondrial cytochrome
c oxidase subunit 1 (CO I) gene; this difference is sufficient to suggest
that the chemotypes represent different species. Each species contains a di
stinct strain of "E. sertula" that differs at four nucleotide sites in the
small subunit ribosomal RNA (SSU rRNA) gene. These results indicate that th
e chemotypes have a genetic basis rather than an environmental cause. Gene
sequences from an Atlantic sample matched sequences from the California che
motype M colonies, suggesting that this type may be cosmopolitan due to tra
nsport on boat hulls.